KPF
BOLD

K2 Principal Fund’s Audentes Therapeutics, Inc BOLD Stock Holding History

K2 Principal Fund’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,680
Closed -$1.54M – 426
2019
Q4 		$1.54M Buy
+25,680
New +$964K 0.13% 180

K2 Principal Fund's BOLD Position: Q1 2020 in Review

K2 Principal Fund sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 25,680 shares — an estimated $1.54M sold.

K2 Principal Fund first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $1.54M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • K2 Principal Fund reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • K2 Principal Fund sold 25,680 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.54M.
  • K2 Principal Fund first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • K2 Principal Fund's Audentes Therapeutics, Inc position peaked at $1.54M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on K2 Principal Fund's 13F filing for Q1 2020, filed 15 May 2020.